HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

Research Dictionary Pharma Mobile

Sign Up FREE or Login

GVYDGREHTV

Subscribe to New Research on GVYDGREHTV

a decameric tumor-specific antigenic peptide

Also Known As:

Gly-Val-Tyr-Asp-Gly-Arg-Glu-His-Thr-Val

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins
- Peptides: 22950
  - Oligopeptides: 168
    - GVYDGREHTV: 2

Experts

1.	Flower, Darren R: 1 article (11/2004)
2.	Coveney, Peter: 1 article (11/2004)
3.	Wan, Shunzhou: 1 article (11/2004)
4.	Stroobant, V: 1 article (07/2001)
5.	Hülsmeyer, M: 1 article (07/2001)
6.	Hillig, R C: 1 article (07/2001)
7.	Coulie, P G: 1 article (07/2001)
8.	Saenger, W: 1 article (07/2001)
9.	Ziegler, A: 1 article (07/2001)

Related Diseases

1.	Neoplasms (Cancer) 11/30/2004 - "Large-scale massively parallel molecular dynamics (MD) simulations of the human class I major histocompatibility complex (MHC) protein HLA-A*0201 bound to a decameric tumor-specific antigenic peptide GVYDGREHTV were performed using a scalable MD code on high-performance computing platforms. "
2.	Melanoma (Melanoma, Malignant) 07/27/2001 - "The heterotrimeric complex of the human major histocompatibity complex (MHC) molecule HLA-A*0201, beta2-microglobulin and the decameric peptide GVYDGREHTV derived from the melanoma antigen (MAGE-A4 protein has been determined by X-ray crystallography at 1.4 A resolution. "

Related Drugs and Biologics

1.	HLA-A*0201 antigen
2.	Antigens